224 related articles for article (PubMed ID: 18671771)
1. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis.
Hazard E; Munakata J; Bigal ME; Rupnow MF; Lipton RB
Value Health; 2009; 12(1):55-64. PubMed ID: 18671771
[TBL] [Abstract][Full Text] [Related]
2. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
[TBL] [Abstract][Full Text] [Related]
3. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
4. Burden of migraine in the United States: disability and economic costs.
Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
[TBL] [Abstract][Full Text] [Related]
5. Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View.
Agosti R
Headache; 2018 May; 58 Suppl 1():17-32. PubMed ID: 29697152
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
Lublóy Á
BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
[TBL] [Abstract][Full Text] [Related]
7. The economic cost of migraine. Present state of knowledge.
de Lissovoy G; Lazarus SS
Neurology; 1994 Jun; 44(6 Suppl 4):S56-62. PubMed ID: 8008226
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of migraine to society.
Ferrari MD
Pharmacoeconomics; 1998 Jun; 13(6):667-76. PubMed ID: 10179702
[TBL] [Abstract][Full Text] [Related]
9. The burden of migraine. A review of cost to society.
Lipton RB; Stewart WF; Von Korff M
Pharmacoeconomics; 1994 Sep; 6(3):215-21. PubMed ID: 10155264
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
[TBL] [Abstract][Full Text] [Related]
11. Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
Gerth WC; Sarma S; Hu XH; Silberstein SD
J Occup Environ Med; 2004 Jan; 46(1):48-54. PubMed ID: 14724478
[TBL] [Abstract][Full Text] [Related]
12. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
[TBL] [Abstract][Full Text] [Related]
13. The Health and Productivity Burden of Migraines in Australia.
Tu S; Liew D; Ademi Z; Owen AJ; Zomer E
Headache; 2020 Nov; 60(10):2291-2303. PubMed ID: 33026675
[TBL] [Abstract][Full Text] [Related]
14. Migraine matters: the role of triptans in relieving the burden in managed care.
Brixner DI; Brandes JL
J Manag Care Pharm; 2004 Aug; 10(4 Suppl B):S2-12; quiz S13-6. PubMed ID: 23570199
[TBL] [Abstract][Full Text] [Related]
15. The economic impact of migraine: an analysis of direct and indirect costs.
Edmeads J; Mackell JA
Headache; 2002 Jun; 42(6):501-9. PubMed ID: 12167138
[TBL] [Abstract][Full Text] [Related]
16. The economics of migraine. Based on a presentation by Stuart O. Schweitzer, PhD.
Am J Manag Care; 1999 Feb; 5(2 Suppl):S91-8. PubMed ID: 10346519
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
18. The migraine ACE model: evaluating the impact on time lost and medical resource Use.
Caro JJ; Caro G; Getsios D; Raggio G; Burrows M; Black L
Headache; 2000 Apr; 40(4):282-91. PubMed ID: 10759932
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilisation and economic burden of migraines among bank employees in China: a probabilistic modelling study.
Wei D; Wong LP; He X; Loganathan T
J Headache Pain; 2024 Apr; 25(1):60. PubMed ID: 38641794
[TBL] [Abstract][Full Text] [Related]
20. Burden of migraine: societal costs and therapeutic opportunities.
Lipton RB; Stewart WF; von Korff M
Neurology; 1997 Mar; 48(3 Suppl 3):S4-9. PubMed ID: 9071263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
